StonvexLoading…
StonvexStonvexStonvexCore line items from IMA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $800.00K | $3.50M | $9.16M | $15.62M |
Operating Income | $-48.45M | $-37.00M | $-75.42M | $-70.90M |
Net Income | $-45.35M | $-36.57M | $-68.17M | $-68.77M |
EPS (Diluted) | $-9.64 | $-22.10 | $-1.63 | $-1.90 |
Total Assets | $152.98M | $15.92M | $192.09M | $172.26M |
Total Liabilities | $19.84M | $17.45M | $22.34M | $25.29M |
Cash & Equivalents | $94.53M | $12.12M | $119.89M | $59.92M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-80.16M | $-75.54M |
Shares Outstanding | 4.87M | 48.26M | 48.26M | 36.26M |